Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Gini

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Rheumatology|August 24, 2020
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasonsIrma Convertino, Ersilia Lucenteforte, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|December 25, 2010
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR ProjectPreciosa M Coloma, Martijn J Schuemie, Gianluca Trifirò, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2012
Electronic healthcare databases for active drug safety surveillance: is there enough leverage?Preciosa M Coloma, Gianluca Trifirò, Martijn J Schuemie, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2024
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'Vieri Lastrucci, Martina Pacifici, Monia Puglia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 2, 2024
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort studyVieri Lastrucci, Martina Pacifici, Monia Puglia, et al.
Health Policy (Amsterdam, Netherlands)|June 27, 2013
Group versus single handed primary care: a performance evaluation of the care delivered to chronic patients by Italian GPsModesta Visca, Andrea Donatini, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2024
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming CodeJohn Tazare, Shirley V Wang, Rosa Gini, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid ArthritisIrma Convertino, Valentina Lorenzoni, Rosa Gini, et al.
Cancers|December 10, 2021
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender ProspectiveAndrea Spini, Rosa Gini, Pietro Rosellini, et al.
Drug Safety|October 30, 2013
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databasesMartijn J Schuemie, Rosa Gini, Preciosa M Coloma, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|August 24, 2020
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasonsIrma Convertino, Ersilia Lucenteforte, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|December 25, 2010
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR ProjectPreciosa M Coloma, Martijn J Schuemie, Gianluca Trifirò, et al.
Pharmacoepidemiology and Drug Safety|February 9, 2012
Electronic healthcare databases for active drug safety surveillance: is there enough leverage?Preciosa M Coloma, Gianluca Trifirò, Martijn J Schuemie, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2024
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'Vieri Lastrucci, Martina Pacifici, Monia Puglia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 2, 2024
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort studyVieri Lastrucci, Martina Pacifici, Monia Puglia, et al.
Health Policy (Amsterdam, Netherlands)|June 27, 2013
Group versus single handed primary care: a performance evaluation of the care delivered to chronic patients by Italian GPsModesta Visca, Andrea Donatini, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2024
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming CodeJohn Tazare, Shirley V Wang, Rosa Gini, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid ArthritisIrma Convertino, Valentina Lorenzoni, Rosa Gini, et al.
Cancers|December 10, 2021
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender ProspectiveAndrea Spini, Rosa Gini, Pietro Rosellini, et al.
Drug Safety|October 30, 2013
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databasesMartijn J Schuemie, Rosa Gini, Preciosa M Coloma, et al.
Pageof 14